PPT-Pharmaceutical Management of Cardiac Medications:

A Look at New Oral Anticoagulants Linda Wing RPh Risik Rask PharmD Nothing to Disclose Identify the characteristics of the ideal anticoagulant and the shortfalls with the current treatment options. San Bernardino/Riverside District Offices. Presenters:. Debra Brown, . PharmD. , Pharmaceutical Consultant. . Edwin Hoffmark, RN, Chief of RN Unit. State of California. Department of Public Health. By Tiffany Steele, SPTA. Objectives:. 1. Cardiovascular Disease (CVD) statistics. 2. Pathophysiological conditions that underlie CVD. 3. The effects of selected medications on Heart Rate (HR), Blood Pressure (BP) responses during exercise/ exercise performance.. eMM. ). Concepts and Definitions. Dr Stephen Chu. Medication . List. A record of prescribed and dispensed medications for an individual. Can be unreconciled or reconciled . Unreconciled Medication List. Tracey . Taynton. Advanced Nurse Practitioner. PMG. Follow Up. Heart Attack/Stent. Review in hospital OPD at 6 weeks. Review with Practice Nurse following CR. Annual review with GP . . for Cholesterol, glucose &. General Statistics. Diagnosed and undiagnosed diabetes in the United States. Total. : .  29.1 million people or 9.3% of the population have diabetes.. Diagnosed:.  21.0 million people.. Undiagnosed:. Paul . G. . T. a. rasi . M.D. .. Staff Anesthesiologist – Allegheny Health Network. Adjunct Clinical Assistant Professor of Anesthesiology – Temple University School of Medicine. Management of Cardiac implanted Electrical devices. Presented by:. Nathan . Funk, MHA, BS. Environmental Health & Safety Officer. WakeMed Health & Hospitals. 3000 New Bern Avenue. Raleigh, NC 27610. (919) 350-8375 Office. WakeMed.org. Objectives. Human Capital Outlook Implications for Skills Development in the Pharmaceutical Sector. Johannesburg. May 27 2015. Disclaimer . Any views or opinions expressed herein are solely those of the author and do not necessarily represent those of any company. B. enefit Management” or “Pharmacy . Benefit Management” . is the set of rules, controls and enforcement tools that define how eligible beneficiaries can obtain third party payment for prescription medicines under a public budget or insurance funded healthcare program. Curtis Smith. November 30, . 2016. Big Data Panel Discussion. Big . Data and the Pharmaceutical Industry. 2. There has been substantial change to the . Pharmaceutical data . environment over the last 5 years. . Here are some cardiac problem signs including chest discomfort, nausea, throat or jaw pain and more which you should never ignore. . M.Pharm. (Ph.D.). Associate Professor. DEPARTMENT OF PHARMACEUTICAL CHEMISTRY. . INTRODUCTION. Also known as . cardiac dysrhythmia . medications.. These are the drugs that are used to . with help from your pharmacist. D. an Martinusen . BSc(Pharm), ACPR, PharmD, FCSHP . Provincial Director - Pharmacy – BC Renal. All content . in this presentation is for . informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Abida Zameer. Harrisburg University. GRAD 699 PGMT. Agenda. Introduction and Problem Statement . Methodology . Results . Discussion. Conclusions. Special . Characterstics. of the pharmaceutical industry .